Microfilament Proteins

Actin filaments (microfilaments) undergo continual polymerization ↔ depolymerization inside cells.
- Growth requires a sufficient pool of ATP-bound globular actin (G-actin).
- Regulation is achieved by a large family of actin-binding proteins, each of which either promotes or restricts filament growth, disassembly, or organization.
Key functional themes:
- Polymerization control (making monomers available or unavailable).
- End-capping (freezing length at + or – ends).
- Cross-linking (forming networks/meshes).
- Severing (controlled breakage of filaments).
- Bundling (packing filaments into tight, ordered arrays).

Growth of a filament depends on the concentration (\$[\text{ATP–G-actin}]\$) relative to the critical concentration (\$C_c\$).
- If \$[\text{ATP–G-actin}] > C_c\$, net elongation occurs.
- If \$[\text{ATP–G-actin}] < C_c\$, net shrinkage occurs.

Binds free ATP–G-actin monomers and sequesters them.
Result: monomers are unavailable for addition to filament ends → polymerization is prevented.
Acts as a buffering reservoir; when released, monomers can rapidly polymerize.

Competes with Thymosin β4 for the same G-actin pool.
When Profilin levels are high:
- G-actin binds Profilin instead of Thymosin β4.
- Profilin–G-actin complex can readily add to the plus (+) end of filaments, favoring elongation.
Serves as a molecular switch that toggles between monomer sequestration and filament growth.

Purpose: "freeze" filament length locally, stabilize structures, or create defined lengths.

Binds the + (barbed) end of microfilaments.
Consequences:
- No further subunit addition.
- No subunit loss from that end.
Frequently localized at the leading edge of motile cells and at Z-discs in muscle sarcomeres, maintaining filament length.

Binds the – (pointed) end of microfilaments.
Blocks both addition and dissociation of actin subunits at that end.
Especially important in muscle fibers, stabilizing thin filaments to precise lengths for optimal contraction.

Joins two intersecting actin filaments at roughly right angles, generating a loose, gel-like network.
Creates flexible 3-D scaffolds that resist shear forces and support the plasma membrane.
Critical for maintaining cell shape and for processes like cytokinesis and lamellipodia formation.

Severs existing actin filaments, producing new ends.
Immediately caps the newly created + ends, preventing uncontrolled re-polymerization.
Functionally allows rapid rearrangement of the cytoskeleton—e.g., during cell movement or platelet activation.
Activation is often Ca²⁺-dependent.

Unlike filamin (which makes cross‐linked nets), bundlers organize filaments into parallel, closely packed bundles that provide rigidity.

Found at sites where the cell forms adhesive contacts with the extracellular matrix during migration (e.g., focal adhesions).
Creates looser bundles (spaced enough to allow insertion of myosin II), facilitating contractility in stress fibers.

Localized primarily in filopodia—slender, actin-rich projections at the leading edge of migrating cells.
Produces very tight bundles (little space between filaments), giving filopodia their stiff, spike-like character.

Filopodia: needle-like protrusions used by migrating cells for environmental sensing and pathfinding.
- Built from Fascin-bundled actin.
Lamellipodia: sheet-like protrusions, supported by branched actin networks cross-linked by Filamin.
Stress fibers: contractile bundles inside cells; α-Actinin arranges actin, allowing myosin II to slide and generate tension.

The cell adjusts concentrations of Thymosin β4 vs. Profilin to control monomer supply.
End-capping dictates where growth or shrinkage can occur, enabling spatial patterning of filament length.
Severing by Gelsolin converts long filaments into shorter fragments that can be re-purposed quickly.
Cross-linking and bundling define architectural motifs:
- Mesh (Filamin) for flexibility.
- Bundles (α-Actinin, Fascin) for rigidity or contractility.

Abnormal regulation of these proteins is implicated in metastatic cancer cell migration, platelet disorders, and cardiomyopathies.
Drugs mimicking capping or severing activities are explored as anti-metastatic agents.

Polymerization occurs when [\text{ATP–G-actin}] > C_c.
Immediately after Gelsolin severing, newly exposed ends are capped within ≈ milliseconds, preventing uncontrolled growth.

Understanding cytoskeletal regulation informs tissue engineering and regenerative medicine but also raises concerns about potential misuse (e.g., enhancing invasive capacity of engineered cells). Responsible research and clinical translation require strict oversight.